Medical Devices: Page 41

  • Multiple black-and-white scans of the lumbar spine next to each other.
    Image attribution tooltip
    HadelProductions via Getty Images
    Image attribution tooltip

    Zimvie to sell spine business for $375M

    Zimvie said the sale to H.I.G. Capital will leave the company focused on its dental business and help reduce debt.

    By • Dec. 18, 2023
  • An embpty bed is surrounded by monitors and hospital equipment.
    Image attribution tooltip
    Martin Barraud via Getty Images
    Image attribution tooltip

    BTIG analysts optimistic medtech will rebound in 2024 after ‘string of rough years’

    Rising interest rates, fears about the impact of GLP-1 drugs and “choppy supply-chain dynamics” dragged on the industry this year, the analysts wrote.

    By • Dec. 18, 2023
  • the FDA Headquarters Explore the Trendline➔
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • The iDose TR implant, made by the Glaukos Corporation
    Image attribution tooltip
    Permission granted by Glaukos Corporation
    Image attribution tooltip

    Glaukos wins FDA approval for drug-releasing eye implant to treat glaucoma

    William Blair analysts said the product “should revolutionize how glaucoma is treated by addressing noncompliance with drops.”

    By • Dec. 15, 2023
  • A person types on a computer with a stethoscope in the background.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem completes US launch of revamped diabetes management platform

    The platform, Tandem Source, combines the features of the company’s legacy t:connect offerings with new data reports.

    By • Dec. 15, 2023
  • An image of Medtronics PulseSelect pulsed field ablation system
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic snags first pulsed field ablation approval in US

    The treatment for atrial fibrillation has gained attention as a safer alternative to radiofrequency and cryoablation. Boston Scientific and Johnson & Johnson are also pursuing the PFA market.

    By • Dec. 14, 2023
  • A Resmed sleep apnea machine
    Image attribution tooltip
    Courtesy of ResMed
    Image attribution tooltip

    Resmed hails ‘significant victory’ as patent board rules in dispute with NYU

    The decisions invalidate claims that NYU argued were infringed by Resmed’s sleep apnea devices.

    By • Dec. 14, 2023
  • Sen. Richard Blumenthal, D-Conn., listens as Sen. Richard Durbin, D-Ill., speaks during a news conference after a hearing on gun violence on Capitol Hill on June 7, 2022.
    Image attribution tooltip
    Alex Wong/Getty Images via Getty Images
    Image attribution tooltip

    In wake of Philips recall, senators urge review of FDA medical device oversight

    Sens. Richard Durbin and Richard Blumenthal said the sleep apnea device maker “did nothing” while patients suffered.

    By • Dec. 14, 2023
  • Office workstation top view of business people working around M&A, keyboard, calculator, phablet and money on wooden table
    Image attribution tooltip
    Atstock Productions via Getty Images
    Image attribution tooltip

    Integra to buy J&J’s Acclarent for $275M

    Integra said the purchase, which includes a portfolio of balloon dilation products for the sinuses and eustachian tube, would make it a market leader in ENT procedures.

    By • Dec. 13, 2023
  • Multiple black-and-white scans of the lumbar spine next to each other.
    Image attribution tooltip
    HadelProductions via Getty Images
    Image attribution tooltip

    Zimvie’s collaboration with Brainlab delivers 510(k) win for spinal fixation system

    Amid recent struggles in its spine unit, Zimvie has been expanding its Brainlab partnership.

    By • Dec. 13, 2023
  • A person wears a blood pressure cuff on their upper arm while another person holds a stethoscope to their arm.
    Image attribution tooltip
    nortonrsx via Getty Images
    Image attribution tooltip

    The FDA approved 2 renal denervation devices. There are still questions about who will benefit.

    The devices from Recor and Medtronic are intended to treat high blood pressure. An advisory panel backed the former, but recommended against approval of the latter.

    By • Dec. 13, 2023
  • A metal, rounded device says "Senza Omnia" and has two attached leads.
    Image attribution tooltip
    Courtesy of Nevro
    Image attribution tooltip

    Activist investor takes stake in Nevro amid struggles to grow neuromodulation sales

    Engaged Capital is opposed to Nevro going after acquisitions that may jeopardize its core business, Bloomberg reported Monday.

    By • Dec. 12, 2023
  • Watchman Flx Pro Left Atrial Appendage Closure Device
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Why heart device makers are investing in left atrial appendage closure

    Medtronic and Johnson & Johnson are pursuing a market that leader Boston Scientific predicts could hit $6 billion by 2030.

    By • Dec. 12, 2023
  • Hologic COO Essex Mitchell
    Image attribution tooltip
    Courtesy of Hologic, Inc.
    Image attribution tooltip

    Hologic promotes Essex Mitchell to COO

    Mitchell joined Hologic as vice president of sales and commercial excellence for the GYN surgical division in 2017.

    By • Dec. 11, 2023
  • A rectangular box with arrows on the front says "Medtronic GI Genius"
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic expands AI endoscopy partnership with Cosmo

    The collaboration will focus on Cosmo Intelligent Medical Devices’ GI Genius module, which Medtronic distributes globally.

    By • Dec. 11, 2023
  • Peter Arduini, GE Healthcare
    Image attribution tooltip
    Courtesy of GE Healthcare
    Image attribution tooltip

    Advamed adds medical imaging division, names new board chair

    The medtech association is bringing on staff from the Medical Imaging & Technology Alliance to lead the new division.

    By • Dec. 11, 2023
  • The BD MiniDraw Capillary Blood Collection System obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.
    Image attribution tooltip
    Courtesy of Becton Dickinson
    Image attribution tooltip

    BD receives 510(k) clearance for fingerstick blood test sample collection device

    The clearance positions BD and partner Babson Diagnostics to support blood collection from community sites such as pharmacies.

    By • Dec. 8, 2023
  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic secures CE mark for rechargeable Percept deep brain stimulation device

    The company plans to make the device available in Western Europe this month and “launch in additional regions based on local regulations.”

    By • Updated Dec. 13, 2023
  • From left to right: A white, rectangular device that says "EO," a black device with a screen that says "EOWatch," and a smartphone.
    Image attribution tooltip
    Courtesy of EOFlow
    Image attribution tooltip

    Medtronic scraps plans to buy insulin patch-pump maker EOFlow

    Medtronic cited “multiple breaches” of the companies’ agreements. EOFlow has been embroiled in patent lawsuits with Insulet this year.

    By • Dec. 7, 2023
  • Signs for Johnson & Johnson are seen on company offices in California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    5 takeaways from J&J’s investor day

    The company outlined its long-term growth expectations and confirmed that it has no plans to separate its medtech and pharma segments.

    By • Dec. 6, 2023
  • A respiratory therapist checks on a patient at a medical center in Chicago, Illinois.
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    US hospitals forecast 9% capex growth to support elective procedure backlog: survey

    The Baird survey of 38 health system CFOs forecasts that hospital capital spending growth in 2024 will slow from a 13% jump this year.

    By • Dec. 6, 2023
  • Johnson & Johnson's new logo is seen on an office lobby wall.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J hernia mesh settlement prompts judge to dismiss more than 200 cases

    The company and claimants in Georgia filed to dismiss cases related to Ethicon’s Physiomesh in late November. 

    By • Dec. 6, 2023
  • Murielle Thinard McLane, managing partner and head of Intuitive Ventures
    Image attribution tooltip
    Courtesy of Intuitive Ventures
    Image attribution tooltip

    Intuitive’s venture capital arm launches second investment fund

    The $150 million fund will back early-stage companies focused on healthcare access, digital health, and precision diagnostics and interventions.

    By • Dec. 5, 2023
  • A machine moves between several rows of test tubes.
    Image attribution tooltip
    Karen Ducey via Getty Images
    Image attribution tooltip

    Laboratory trade group, providers oppose FDA’s lab developed test proposal

    A CDRH spokesperson confirmed to MedTech Dive that a discrepancy in the submission system used for the proposed rule led to an initial overcount of public comments.

    By • Updated Dec. 7, 2023
  • A windowed building surrounded by trees with a sign "Baxter" in front
    Image attribution tooltip
    Tim Boyle via Getty Images
    Image attribution tooltip

    Baxter sends another safety notice about syringe infusion pump errors

    The company shared “reinforced guidance” to mitigate the risk of underdosing and interruptions to treatment.

    By • Updated Dec. 6, 2023
  • Professional photo of Kevin Thornal
    Image attribution tooltip
    Courtesy of Nevro
    Image attribution tooltip

    Nevro buys low back pain company Vyrsa for $40M

    The company expects the acquisition to be revenue accretive starting in 2024.

    By • Dec. 4, 2023